News

SuccessEHS said that its Mobile EHR is a convenient and portable way for physicians to review summary patient data and dictate into SuccessEHS EHR. SuccessEHS said that by

SDIS is a solution that closes a major gap in the nonclinical phase of the R&D lifecycle and also creates an instantly searchable resource of all nonclinical study

Antares claims that its new Vibex QS auto-injector platform offers a dose capacity of 1ml and greater in a compact design. Additionally, the new design also accommodates fast

Pfizer said that Axitinib is an oral and selective inhibitor of vascular endothelial growth factor (VEGF) receptors 1, 2 and 3. Pfizer Oncology Business Unit Clinical Development senior

Of the additional sites, the Stanford Cancer Center (Stanford, California) under principal investigator Jason Gotlib, has already commenced enrolling patients, additionally the company will start recruiting patients in

Ziopharm said that the preclinical work was designed to study darinaparsin’s cytotoxic and radiosensitizing effects against different solid tumor cell lines under both normoxic (NO) and hypoxic (HO)

J&J and Takeda, which co-market Velcade, said the impurities were made of a white polyester like material that stemmed from a filtration system used in the manufacturing process.

Elorac said that in two phase III pivotal double-blind, randomised, vehicle-controlled, paired-comparison, multi-center studies, the results showed reductions in acne lesion counts after 8 and 12 weeks of

Researchers at Marina Biotech have identified new DiLA2-based formulations composed of multiple DiLA2 molecules, that when paired with a UsiRNA targeting FVII mRNA in liver (hepatocytes) of mice,